Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Perform SNP Genotyping for University of Cambridge

NEW YORK, Aug. 27 - Illumina today said it will perform SNP genotyping services on certain diabetes-related samples provided by the University of Cambridge Institute for Medical Research.


Illumina said it will design functional assays for CIMR's SNP loci and use its BeadArray technology to genotype certain SNPs in some 3,000 samples.


CIMR houses the Juvenile Diabetes Research Foundation and the Diabetes and Inflammatory Laboratory funded by the Wellcome Trust.


Click here for more information.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.